Form 4: Elanco Animal Health Executive Acquires Deferred Stock Units

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Summary

• On August 9, 2024, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units.
• The transaction involved 106.1825 deferred stock units, each representing the right to receive one share of Elanco's common stock or the cash equivalent.
• The price of the derivative security was $13.04.
• Following the reported transaction, Modi beneficially owns 1,465.4689 derivative securities.
• These deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard executive compensation transaction. It's neither overwhelmingly positive nor negative.

Positives

• The acquisition of deferred stock units by an executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in the animal health industry, where stock-based compensation is used to align executive interests with shareholder value.

Comparison to Industry Standards

• Stock-based compensation is a common practice across the pharmaceutical and animal health industries.
• Companies like Zoetis and Merck Animal Health also utilize stock options and restricted stock units as part of their executive compensation packages.
• The specific terms and amounts of these awards vary based on company size, performance, and individual executive roles.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.

Key Dates